계명대학교 의학도서관 Repository

Piceatannol in combination with low doses of cyclosporine a prolongs kidney allograft survival in a stringent rat transplantation model

Metadata Downloads
Author(s)
LUIS A. FERNANDEZJOSE TORREALBAG¨OKHAN YAGCINOBUHIRO ISHIDOMASAHIRO TSUCHIDAHYOUNG TAE KIMYINCHEN DONGTERRY OBERLEYJOHN FECHNERMATTHEW J. COLBURNJACKIE SCHULTZTURAN KANMAZHUAIZHONG HUSTUART J. KNECHTLEMAJED M. HAMAWY
Keimyung Author(s)
Kim, Hyoung Tae
Department
Dept. of Surgery (외과학)
Journal Title
Transplantation
Issued Date
2002
Volume
74
Issue
11
Abstract
Background. The discovery of new immunosuppressive agents has enhanced short-term graft survival. However, current immunosuppressants often induce toxicities that limit their clinical use. Thus, there is a need for new immunosuppressants for use in clinical transplantation. Piceatannol blocks Syk and ZAP-70, tyrosine kinases involved in immune cell activation. We examined whether piceatannol prolongs kidney allograft survival in the stringent ACI-to-Lewis rat model.



Methods. Kidney recipients were divided into four groups. Group 1 (n=8) received piceatannol 30 mg/kg per day intravenously and cyclosporine A (CsA) 2 mg/kg per day intramuscularly from day -3 to day 7 after transplantation. At day 8, piceatannol was reduced to 10 mg/kg per day and the combined treatment continued until day 60. Group 2 (n=9) received 2 mg/kg per day CsA alone from day -3 to day 60. Group 3 (n=4) received piceatannol alone as in group 1. Group 4 (n=2) received only the vehicle dimethyl sulfoxide from day -3 to day 60. Graft rejection was defined as either a serum creatinine level more than 2 mg/dL or animal death.



Results. Group 1 animals survived for at least 115 days (n=8, P <0.05), with several animals maintaining their grafts for more than 200 days. In contrast, 8 of 9 animals in group 2 rejected their grafts within 10 days of transplantation; one animal survived for 71 days. Excellent graft function was maintained in group 1 animals despite withdrawal of immunosuppression.



Conclusions. These results are the first to show that piceatannol, when combined with subtherapeutic dosages of CsA, prevents graft rejection, suggesting that targeting Syk and Zap could be useful for preventing graft rejection.
Keimyung Author(s)(Kor)
김형태
Publisher
School of Medicine
Citation
LUIS A. FERNANDEZ et al. (2002). Piceatannol in combination with low doses of cyclosporine a prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation, 74(11), 1609–1617. doi: 10.1097/01.TP.0000041447.91134.24
Type
Article
ISSN
0041-1337
Source
https://insights.ovid.com/pubmed?pmid=12490796
DOI
10.1097/01.TP.0000041447.91134.24
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/34709
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
Authorize & License
  • Authorize공개
  • EmbargoForever
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.